{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T05:08:32Z","timestamp":1778389712083,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General and Comparative Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ygcen.2025.114745","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T20:35:01Z","timestamp":1746736501000},"page":"114745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus \u03b1Latrotoxin and Heloderma Exendin-4"],"prefix":"10.1016","volume":"368","author":[{"given":"Oleg G.","family":"Chepurny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber N.","family":"Liles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Cham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minos-Timotheos","family":"Matsoukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Liapakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghe","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygcen.2025.114745_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2164-12-14","article-title":"Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis","volume":"12","author":"Atwood","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ygcen.2025.114745_b0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/joim.12837","article-title":"Peptide-based multi-agonists: a new paradigm in metabolic pharmacology","volume":"284","author":"Brandt","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ygcen.2025.114745_b0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.peptides.2017.12.021","article-title":"Gut hormone polyagonists for the treatment of type 2 diabetes","volume":"100","author":"Brandt","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.ygcen.2025.114745_b0020","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ygcen.2025.114745_b0025","doi-asserted-by":"crossref","first-page":"28934","DOI":"10.1038\/srep28934","article-title":"Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategy","volume":"6","author":"Chepurny","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygcen.2025.114745_b0030","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1038\/s41598-018-22106-1","article-title":"Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors","volume":"8","author":"Chepurny","year":"2018","journal-title":"Sci. Rep.."},{"key":"10.1016\/j.ygcen.2025.114745_b0035","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1074\/jbc.RA118.005682","article-title":"Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP","volume":"294","author":"Chepurny","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00125-023-06010-6","article-title":"ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis","volume":"67","author":"Chhabra","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygcen.2025.114745_b0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41574-018-0118-x","article-title":"Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases","volume":"15","author":"Clemmensen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ygcen.2025.114745_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3293176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type-2 diabetes mellitus","volume":"18","author":"Coskun","year":"2018","journal-title":"Molec. Metabol."},{"key":"10.1016\/j.ygcen.2025.114745_b0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nchembio.209","article-title":"A new glucagon and GLP-1 co-agonist eliminates obesity in rodents","volume":"5","author":"Day","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ygcen.2025.114745_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41467-021-27760-0","article-title":"Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation","volume":"13","author":"Deganutti","year":"2022","journal-title":"Nat. Commun..,"},{"issue":"1","key":"10.1016\/j.ygcen.2025.114745_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41392-024-01810-7","article-title":"Dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1\/LPHN1) increases the risk of obesity","volume":"9","author":"Dietzsch","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ygcen.2025.114745_b0075","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1021\/acs.jmedchem.7b00174","article-title":"Design of novel exendin-based dual glucagon-like peptide 1 (GLP-1)\/Glucagon receptor agonists","volume":"60","author":"Evers","year":"2017","journal-title":"J. Med. Chem.."},{"key":"10.1016\/j.ygcen.2025.114745_b0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A rationaly designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ygcen.2025.114745_b0090","doi-asserted-by":"crossref","first-page":"35581","DOI":"10.1074\/jbc.M113.512046","article-title":"A novel glucagon-like peptide-1 (GLP-1)\/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice","volume":"288","author":"Gault","year":"2013","journal-title":"J. Biol. Chem.."},{"key":"10.1016\/j.ygcen.2025.114745_b0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0014-5793(95)01070-U","article-title":"Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release","volume":"373","author":"Gromada","year":"1995","journal-title":"FEBS Lett.."},{"key":"10.1016\/j.ygcen.2025.114745_b0100","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/acs.molpharmaceut.0c00995","article-title":"Stapled, long-acting Xenopus GLP-1-based dual GLP-1\/Glucagon receptor agonists with potent therapeutic efficacy for metabolic disease","volume":"18","author":"Han","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ygcen.2025.114745_b0105","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ygcen.2025.114745_b0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0305-0491(98)10088-3","article-title":"Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones. Comp. Biochem. Physiol. Pt. B","volume":"121","author":"Holz","year":"1998","journal-title":"Biochem. Molec. Biol."},{"key":"10.1016\/j.ygcen.2025.114745_b0120","first-page":"S295","article-title":"Deorphanization of black widow spider GLP-1: validation of GLP-1 receptor agonist action relevant to human islet insulin secretion in vitro. 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Holz","year":"2022","journal-title":"Stockholm, Sweden, Diabetologia."},{"key":"10.1016\/j.ygcen.2025.114745_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735019","article-title":"Striking the balance: GLP-1\/glucagon co-agonism as a treatment strategy for obesity","volume":"12","author":"Hope","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ygcen.2025.114745_b0130","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1074\/jbc.274.9.5491","article-title":"A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors","volume":"274","author":"Ichtchenko","year":"1999","journal-title":"J. Biol. Chem.."},{"key":"10.1016\/j.ygcen.2025.114745_b0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","article-title":"Generic GPCR residue numbers\u2013aligning topology maps while minding the gaps","volume":"36","author":"Isberg","year":"2015","journal-title":"Trends Pharmacol. Sci.,"},{"key":"10.1016\/j.ygcen.2025.114745_b0140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Retatrutide phase 2 obesity trial investigators. Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.ygcen.2025.114745_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113118","article-title":"Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)\/glucagon receptor agonists","volume":"212","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0150","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/s41467-022-31328-x","article-title":"A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun.."},{"key":"10.1016\/j.ygcen.2025.114745_b0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1515\/hsz-2021-0146","article-title":"The relevance of adhesion G protein-coupled receptors in metabolic functions","volume":"403","author":"Kaczmarek","year":"2021","journal-title":"Biol.. Chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The Glucagon-like Peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endo. Rev."},{"key":"10.1016\/j.ygcen.2025.114745_b0165","doi-asserted-by":"crossref","first-page":"28692","DOI":"10.1074\/jbc.M504913200","article-title":"A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122513","article-title":"Fourth-generation Epac-based FRET sensors for cAMP feature exceptional brightness, photostability and dynamic range: characterization of dedicated sensors for FLIM, for ratiometry and with high affinity","volume":"10","author":"Klarenbeek","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygcen.2025.114745_b0175","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(00)80332-3","article-title":"alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor","volume":"18","author":"Krasnoperov","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.ygcen.2025.114745_b0180","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1152\/physrev.00027.2021","article-title":"Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology","volume":"102","author":"Lala","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ygcen.2025.114745_b0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pbiomolbio.2011.07.005","article-title":"Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic \u03b2 cells","volume":"107","author":"Leech","year":"2011","journal-title":"Prog. Biophys. Molec. Biol."},{"key":"10.1016\/j.ygcen.2025.114745_b0190","doi-asserted-by":"crossref","first-page":"21504","DOI":"10.1074\/jbc.272.34.21504","article-title":"Alpha-latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptors","volume":"272","author":"Lelianova","year":"1997","journal-title":"J. Biol. Chem.."},{"key":"10.1016\/j.ygcen.2025.114745_b0195","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/dom.14693","article-title":"The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db\/db mice","volume":"24","author":"Meng","year":"2022","journal-title":"Diabet. Obes. Metabol."},{"key":"10.1016\/j.ygcen.2025.114745_b0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/en.2003-1099","article-title":"Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells","volume":"145","author":"Merglen","year":"2004","journal-title":"Endocrinol."},{"key":"10.1016\/j.ygcen.2025.114745_b0205","doi-asserted-by":"crossref","first-page":"e3641","DOI":"10.21769\/BioProtoc.3641","article-title":"FRET reporter assays for cAMP and calcium in a 96-well format using genetically encoded biosensors expressed in living cells","volume":"10","author":"Milliken","year":"2020","journal-title":"Bio-Protocol."},{"key":"10.1016\/j.ygcen.2025.114745_b0210","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/acs.jmedchem.0c01783","article-title":"Design and evaluation of peptide dual-agonists of GLP-1 and NPY2 receptors for glucoregulation and weight loss with mitigated nausea and emesis","volume":"64","author":"Milliken","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0220","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s42255-023-00812-z","article-title":"Gut hormone co-agonists for the treatment of obesity: from bench to bedside","volume":"5","author":"Nogueiras","year":"2023","journal-title":"Nat. Metabol."},{"key":"10.1016\/j.ygcen.2025.114745_b0225","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.celrep.2019.01.040","article-title":"Involvement of the adhesion GPCRs latrophilins in the regulation of insulin release","volume":"26","author":"R\u00f6the","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ygcen.2025.114745_b0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s42003-024-05783-9","article-title":"The adhesion GPCR GPR116\/ADGRF5 has a dual function in pancreatic islets regulating somatostatin release and islet development","volume":"7","author":"R\u00f6the","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ygcen.2025.114745_b0235","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00125-017-4354-8","article-title":"GLP-1\/glucagon receptor co-agonism for treatment of obesity","volume":"60","author":"S\u00e1nchez-Garrido","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygcen.2025.114745_b0240","first-page":"670","article-title":"Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus","volume":"84","author":"Seufert","year":"1999","journal-title":"J. Clin.. Endocrinol. Metab.,"},{"key":"10.1016\/j.ygcen.2025.114745_b0245","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/dom.12685","article-title":"Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'","volume":"18","author":"Skow","year":"2016","journal-title":"Diab. Obes. Metabol."},{"key":"10.1016\/j.ygcen.2025.114745_b0250","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/diab.42.11.1678","article-title":"Cloning and functional expression of the human islet GLP-1 receptor. demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor","volume":"42","author":"Thorens","year":"1993","journal-title":"Diabetes."},{"key":"10.1016\/j.ygcen.2025.114745_b0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90006","article-title":"Coordination between ECM and cell-cell adhesion regulates the development of islet aggregation, architecture, and functional maturation","volume":"12","author":"Tixi","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.ygcen.2025.114745_b0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-540-74805-2_7","article-title":"-Latrotoxin and its receptors","volume":"184","author":"Ushkaryov","year":"2008","journal-title":"Handbook Expt. Pharmacol."},{"key":"10.1016\/j.ygcen.2025.114745_b0265","doi-asserted-by":"crossref","first-page":"14065","DOI":"10.1074\/jbc.REV120.007423","article-title":"Mechanisms of adhesion G protein-coupled receptor activation","volume":"295","author":"Vizurraga","year":"2020","journal-title":"J. Biol.chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0270","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2 - A multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics."},{"key":"10.1016\/j.ygcen.2025.114745_b0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ygcen.2025.114745_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115036","article-title":"Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1\/glucagon\/Y2 receptor triple agonist","volume":"247","author":"Yuan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ygcen.2025.114745_b0285","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molcel.2020.09.020","article-title":"Differential GLP-1R binding and activation by peptide and non-peptide agonists","volume":"80","author":"Zhang","year":"2020","journal-title":"Molec. Cell"}],"container-title":["General and Comparative Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016648025000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016648025000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:12:38Z","timestamp":1778386358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016648025000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"alternative-id":["S0016648025000851"],"URL":"https:\/\/doi.org\/10.1016\/j.ygcen.2025.114745","relation":{},"ISSN":["0016-6480"],"issn-type":[{"value":"0016-6480","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus \u03b1Latrotoxin and Heloderma Exendin-4","name":"articletitle","label":"Article Title"},{"value":"General and Comparative Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygcen.2025.114745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114745"}}